# Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

> **NCT06565273** · PHASE2 · RECRUITING · sponsor: **SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** FBL-MTX

## Key facts

- **NCT ID:** NCT06565273
- **Lead sponsor:** SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-24
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06565273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06565273, "Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06565273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*